Blissco Expands Leadership & Executive Team to Accelerate National & International Growth Strategy

Not for distribution in the U.S. or to U.S. Newswires

VANCOUVER, British Columbia, Feb. 14, 2019 (GLOBE NEWSWIRE) — Blissco Cannabis Corp. (CSE: BLIS) (OTCQB: HSTRF) (FRA: GQ4B), (“Blissco”) or the (“Company”) is a Canadian wellness cannabis brand based in British Columbia and licensed processor, producer, and distributor of premium dried cannabis and cannabis oil. The Company is pleased to announce that it has added a new Chief Technology Officer, Brand and PR Director, and Marketing Manager to its team.

These additions will help the Company accelerate its strategic priorities and establish Blissco as a national and international brand, providing innovative and quality assured, full spectrum cannabis products to the world.

“This is an exciting time for Blissco as we ship more than 85,000 cannabis units in Canada over the next seven weeks,” said Blissco CEO, Damian Kettlewell. “Blissco’s team is committed to delivering innovative, quality assured full spectrum cannabis products and providing personal and informative client care. It is vital that we have the best team to make this vision a reality.”

Blissco is pleased to announce the appointment of Robin Killeen as our Chief Technology Officer. Mr. Killeen previously spent 13 years with Great Canadian Gaming Corporation, where he served as Director of Technical Development. Great Canadian Gaming Corporation, Canada’s largest gaming company, is publicly listed with a market cap of $3 billion and 30 locations throughout Canada and Washington. He also brings significant manufacturing and logistics knowledge and experience coordinating shipments across sectors.

Jennifer Engele is Blissco’s newly appointed Brand and PR Director. Ms. Engele has over 20 years of marketing experience including ten years with Pharmasave Drugs, a leading Canadian pharmacy and drugstore retailer with over 650 locations; and more than a decade with JOEY Restaurants, an upscale restaurant chain with locations throughout Canada and the U.S. Ms. Engele most recently held the position of National Manager of Marketing and Communications for Pharmasave and before that, Director of Marketing for JOEY Restaurants.

Additionally, Blissco has appointed Cesar Chung to the role of Marketing Manager. Mr. Chung spent 20 years with Johnson & Johnson Medical Devices Companies, one of the world’s largest medical companies, where he played a significant role as Digital Marketing Manager for Animas North America.
 
About Blissco Cannabis Corp.

Blissco Cannabis Corp. (CSE: BLIS) (OTCQB: HSTRF) (FRA: GQ4B) is a Canadian wellness cannabis brand based in British Columbia and a multi-licensed processor, cultivator and distributor of premium cannabis.

Blissco owns and operates a state-of-the-art GPP facility located in Metro Vancouver, British Columbia with 18,000 square feet of extraction, cultivation and processing rooms. Blissco is supplying premium cannabis and small-batch Reserve whole flower and pre-rolls to the Canadian and global marketplace with a growing list of provincial cannabis boards and international distribution partners.

With a license to process cannabis oil acquired in August 2018, Blissco’s extraction lab is also in operation preparing a line of full spectrum oils for distribution in 2019.

Learn more at blissco.com.


On Behalf of the Board of Directors

BLISSCO CANNABIS CORP.

Damian Kettlewell, CEO, Founder & Chair

For further information please contact:
1 604 484-9119
investors@blissco.com

Cautionary Statements

This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation (collectively “forward-looking statements”). The use of any of the word “will” and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Such forward-looking statements should not be unduly relied upon. This news release contains forward-looking statements and assumptions pertaining to the following: the ability to execute on our strategic plans and the impact on our future operations, capital expenditures, receipt of a cannabis oil license and a license to sell dried cannabis and other objectives. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors. The Company believes the expectations reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct. The Company does not undertake to update these forward-looking statements, except as required by law.

The CSE has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.